LAS VEGAS, Dec. 10, 2024 (GLOBE NEWSWIRE) -- via IBN – BioAdaptives, Inc. (OTC: BDPT) is thrilled to announce the launch of Xcellara™ Stem Cell Activator, a groundbreaking supplement that harnesses ...
New findings reveal how cancer manipulates immune pathways and highlight therapeutic strategies to unleash T-cells against even the most resistant tumors. Study: Cancer cells impair monocyte-mediated ...
Nanotein engages Akron Bio for the cGMP production of its NanoSpark™ STEM-T Soluble T Cell Activator
BERKELEY, Calif.--(BUSINESS WIRE)--Nanotein Technologies, Inc. (“Nanotein”), a technology development company with next-generation immune cell activation reagents leveraging its proprietary NanoSpark® ...
Sartorius Stedim Biotech and Nanotein Technologies entered into a partnership which will include Sartorius investing up to $3 million in a minority shareholding in Nanotein Technologies. This will ...
Findings highlight RedTail’s potential to overcome historical limitations of T-cell engagers in solid tumors through tumor-specific, localized expression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results